Hepatitis Viruses for NEET PG Microbiology: HAV, HBV Serology, HCV, HDV and HEV, With India's HBV Birth-Dose and Pregnancy Screening

Start Here

🎯 Exam priority: Very high. Expect: which hepatitis viruses are faecal–oral and which become chronic, HBV markers (HBsAg, IgM anti-HBc, anti-HBs, HBeAg) and the window period, chronicity by age at infection, HCC with or without cirrhosis, HCV genotypes and DAAs, HDV coinfection vs superinfection, HEV in pregnancy and pigs, and India's HBsAg screening, HBIG and birth-dose rules.

CBME mapping: MI4.7–4.8. Fact-checked against the MSD Manual, the NACO EVTHS guidelines (2024) and the MoHFW UIP (2026).

Hepatitis A to E viruses, HBV serology, HCV and Indian prevention of mother-to-child transmission

Hepatitis A–E, HBV serology, HCV and Indian prevention. Drawn by TrackNation.

Hepatitis A and E: Faecal–Oral (MSD)

  • HAV and HEV spread faecal–orally; hepatitis B and C predispose to chronic hepatitis and liver cancer, hepatitis A does not.

  • HAV: enterically transmitted RNA virus; young children often asymptomatic; no chronic carrier state, no cirrhosis. IgM anti-HAV = acute infection; total anti-HAV = immunity. Immune globulin protects non-immune contacts; vaccine available.

  • HEV: four genotypes; genotypes 1 and 2 cause waterborne outbreaks (Asia, Africa); genotype 3 is zoonotic (pigs) and can become chronic in the immunocompromised. Liver failure and death are rare except in pregnancy.

Hepatitis B: Serology and Chronicity (MSD)

Hepatitis B serological markers over time in resolving acute infection, the window period, and a table to interpret acute, chronic, past and vaccinated patterns

Hepatitis B markers over time, the window period, and how to read the serology panel. Drawn by TrackNation.

  • HBV is a DNA virus spread parenterally, sexually (body fluids) and from mother to child — babies of infected mothers have a 70–90% risk at delivery without HBIG and vaccine.

  • Markers: HBsAg appears in the incubation period, 1–6 weeks before illness, and implies infectivity; IgM anti-HBc marks acute infection and fills the window period (HBsAg gone, anti-HBs not yet present); anti-HBs appears after recovery and gives lifelong immunity; HBeAg suggests active replication.

  • Chronicity depends on age at infection: infants 80–90%, children 1–5 years ~30%, adults 1–12%. HBV can cause hepatocellular carcinoma even without cirrhosis.

  • Chronic HBV: oral tenofovir or entecavir control but do not cure the virus; tenofovir in the third trimester for high viral loads reduces vertical spread.

Hepatitis C and D (MSD)

  • HCV: RNA virus spread mainly by blood — shared needles, unsterile tattoos; sexual and vertical spread are uncommon; no vaccine. Acute infection becomes chronic in 65–85%; cirrhosis in 15–30% over 20 years; HCC mostly after cirrhosis.

  • Six genotypes (genotype 1 commonest in the US). Direct-acting antivirals can permanently clear the virus — pangenotypic sofosbuvir/velpatasvir or glecaprevir/pibrentasvir. Extrahepatic: mixed cryoglobulinaemia, porphyria cutanea tarda; HCV recurs in liver grafts.

  • HDV (delta agent): a defective RNA virus that replicates only with HBV — as coinfection with acute hepatitis B or superinfection of chronic hepatitis B.

India: Preventing Mother-to-Child HBV (NACO, UIP)

  • Every pregnant woman is screened for HBsAg at first contact, preferably in the first trimester (and in labour if unscreened).

  • HBsAg-positive women are high-risk pregnancies delivered at centres with vaccine and HBIG; HBV is not a reason for termination or for caesarean section; refer to NVHCP treatment sites.

  • The newborn gets HBIG plus the hepatitis B birth-dose vaccine immediately after delivery; under the UIP the birth dose is given as early as possible, within 24 hours.

Traps the Examiner Sets

  • In the window period HBsAg and anti-HBs are both negative — only IgM anti-HBc is positive.

  • Anti-HBs alone = immunity (vaccine or recovery); HBsAg = current infection.

  • The younger the age at HBV infection, the higher the chance of chronic infection.

  • HEV is dangerous in pregnancy; HAV never becomes chronic.

  • HDV needs HBV — preventing HBV prevents HDV.

Memory Hooks & Shortcuts

Shortcuts to lock in this article's numbers and lists. Each one only re-packages facts proven above.

  • 🧠 'Vowels hit the Bowels' — hepatitis A and E are faecal–oral — routes

  • 🧠 'B is a DNA Boss; the rest are RNA' — genomes

  • 🧠 Window period: 'S is gone, S-antibody not yet — Core IgM holds the Fort' — HBV serology

  • 🧠 'The younger the host, the longer B stays' — 80–90% of infants, 1–12% of adults — chronicity

  • 🧠 'E for Expectant mothers in danger' — HEV

Rapid-Revision Cards

  • Faecal–oral

    HAV, HEV.

  • Chronic

    HBV, HCV (and HDV).

  • HAV

    RNA; no carrier; IgM anti-HAV acute.

  • HBV genome

    DNA.

  • HBsAg

    1–6 wk before illness; infectivity.

  • Window period

    Only IgM anti-HBc.

  • Anti-HBs

    Recovery or vaccine immunity.

  • HBeAg

    Active replication.

  • HBV chronicity

    Infants 80–90%; adults 1–12%.

  • Vertical HBV

    70–90% without prophylaxis.

  • HBV + HCC

    Even without cirrhosis.

  • HBV drugs

    Tenofovir, entecavir (control).

  • HCV spread

    Needles; sexual/vertical rare; no vaccine.

  • HCV chronic

    65–85%; cirrhosis 15–30%/20 y.

  • HCV cure

    DAAs: sofosbuvir/velpatasvir.

  • HCV extrahepatic

    Cryoglobulinaemia, PCT.

  • HDV

    Needs HBV; co- or superinfection.

  • HEV

    G1/2 waterborne; G3 pigs.

  • HEV danger

    Pregnancy.

  • NACO HBV

    Universal HBsAg in pregnancy; HBIG + vaccine.

  • UIP HepB

    Birth dose within 24 h.

Sources

Facts in this article were checked against these documents.

  • MSD Manual Professional: Overview of Acute Viral Hepatitis; Hepatitis A; Hepatitis B (acute, chronic); Hepatitis C (acute, chronic); Hepatitis D; Hepatitis E — Merck & Co. (MSD Manuals), 2024–26 (link)

  • National Guidelines for Elimination of Vertical Transmission of HIV and Syphilis (chapter 8: Hepatitis B) — National AIDS Control Organisation, MoHFW, 2024

  • Universal Immunization Programme — Ministry of Health and Family Welfare, Government of India, 2026

  • Competency Based Undergraduate Curriculum, Vol I: Microbiology (MI4.7–4.8) — National Medical Commission, 2024

Test Yourself: Practice Questions

Thirty questions in NEET PG style, many of them clinical and serology scenarios.

Practice Questions (NEET PG pattern)

Original questions written in the style of the exam: +4 for a correct answer, −1 for a wrong one. Every answer was checked against the sources listed above. NEET PG papers are not published by NBEMS, so these are not past-paper questions.

Q1. Hepatitis viruses spread mainly by the faecal–oral route are

  • (a) C and D

  • (b) B and D

  • (c) B and C

  • (d) A and E

Show answer

Answer: (d) — MSD.


Q2. Hepatitis A

  • (a) is a DNA virus

  • (b) becomes chronic in 10%

  • (c) has no chronic carrier state

  • (d) causes HCC

Show answer

Answer: (c) — MSD.


Q3. Acute hepatitis A is diagnosed by

  • (a) HBsAg

  • (b) HAV culture

  • (c) total anti-HAV

  • (d) IgM anti-HAV

Show answer

Answer: (d) — Total = immunity.


Q4. Hepatitis B virus has a genome of

  • (a) positive-sense RNA

  • (b) DNA

  • (c) defective RNA

  • (d) negative-sense RNA

Show answer

Answer: (b) — MSD.


Q5. The first serological marker to appear in acute HBV, before symptoms, is

  • (a) anti-HBs

  • (b) anti-HBe

  • (c) HBsAg

  • (d) IgG anti-HBc

Show answer

Answer: (c) — 1–6 weeks before illness.


Q6. During the window period of acute hepatitis B, the only positive marker is

  • (a) HBsAg

  • (b) anti-HBs

  • (c) HBeAg

  • (d) IgM anti-HBc

Show answer

Answer: (d) — MSD.


Q7. A vaccinated health worker who never had hepatitis B will be positive for

  • (a) anti-HBs only

  • (b) HBsAg

  • (c) IgM anti-HBc

  • (d) HBeAg

Show answer

Answer: (a) — Anti-HBs = immunity.


Q8. Presence of HBeAg in an HBsAg-positive patient suggests

  • (a) recovery

  • (b) HDV superinfection

  • (c) immunity

  • (d) active viral replication and high infectivity

Show answer

Answer: (d) — MSD.


Q9. The risk of chronic infection after acute HBV is highest when infection occurs in

  • (a) adulthood

  • (b) old age

  • (c) adolescence

  • (d) infancy (80–90%)

Show answer

Answer: (d) — Adults 1–12%.


Q10. Without prophylaxis, a baby born to an HBV-infected mother has a risk of infection at delivery of about

  • (a) 25%

  • (b) 5%

  • (c) 70–90%

  • (d) under 1%

Show answer

Answer: (c) — Give HBIG + vaccine.


Q11. Hepatocellular carcinoma can develop even without cirrhosis in

  • (a) hepatitis D alone

  • (b) hepatitis A

  • (c) acute hepatitis E

  • (d) chronic hepatitis B

Show answer

Answer: (d) — HCV mostly after cirrhosis.


Q12. Chronic hepatitis B is treated with

  • (a) ribavirin

  • (b) interferon only as a cure

  • (c) tenofovir or entecavir, which control but do not cure

  • (d) sofosbuvir

Show answer

Answer: (c) — MSD.


Q13. The commonest route of hepatitis C transmission is

  • (a) sharing needles and other blood exposure

  • (b) faecal–oral

  • (c) mother to child

  • (d) sexual contact

Show answer

Answer: (a) — Sexual and vertical are uncommon.


Q14. The proportion of acute hepatitis C infections that become chronic is

  • (a) 20%

  • (b) 100%

  • (c) 1–5%

  • (d) 65–85%

Show answer

Answer: (d) — MSD.


Q15. A vaccine is available for all EXCEPT

  • (a) hepatitis A

  • (b) none

  • (c) hepatitis B

  • (d) hepatitis C

Show answer

Answer: (d) — No HCV vaccine.


Q16. Chronic hepatitis C can now be permanently cleared with

  • (a) tenofovir

  • (b) interferon-gamma

  • (c) direct-acting antivirals such as sofosbuvir/velpatasvir

  • (d) acyclovir

Show answer

Answer: (c) — Pangenotypic.


Q17. An extrahepatic manifestation typical of chronic HCV is

  • (a) Reye syndrome

  • (b) erythema nodosum leprosum

  • (c) aplastic anaemia only

  • (d) mixed cryoglobulinaemia

Show answer

Answer: (d) — Also PCT.


Q18. Chronic HCV leads to cirrhosis in about

  • (a) 15–30% over 20 years

  • (b) 50% in 1 year

  • (c) 1% ever

  • (d) 90% in 5 years

Show answer

Answer: (a) — MSD.


Q19. Hepatitis D can replicate only in the presence of

  • (a) hepatitis C virus

  • (b) HIV

  • (c) hepatitis A virus

  • (d) hepatitis B virus

Show answer

Answer: (d) — Defective RNA.


Q20. HDV infecting a person who already has chronic hepatitis B is called

  • (a) seroconversion

  • (b) reactivation

  • (c) superinfection

  • (d) coinfection

Show answer

Answer: (c) — Coinfection = with acute HBV.


Q21. Waterborne epidemics of hepatitis in India and Asia are typically due to

  • (a) HDV

  • (b) HAV only

  • (c) HCV

  • (d) HEV genotypes 1 and 2

Show answer

Answer: (d) — Faecal contamination of water.


Q22. Hepatitis E is especially dangerous in

  • (a) vaccinated adults

  • (b) smokers

  • (c) children under 5

  • (d) pregnancy

Show answer

Answer: (d) — MSD.


Q23. The main animal reservoir of zoonotic HEV is the

  • (a) bat

  • (b) rat

  • (c) pig

  • (d) monkey

Show answer

Answer: (c) — Genotype 3.


Q24. Chronic hepatitis E has been reported in

  • (a) children only

  • (b) immunocompromised patients such as transplant recipients

  • (c) never

  • (d) all pregnant women

Show answer

Answer: (b) — Genotype 3.


Q25. Under NACO's EVTHS guidelines, HBsAg screening in pregnancy is

  • (a) only in labour

  • (b) only for high-risk women

  • (c) universal, preferably in the first trimester

  • (d) not recommended

Show answer

Answer: (c) — NACO 2024.


Q26. An HBsAg-positive pregnant woman should be

  • (a) given hepatitis B vaccine for herself

  • (b) managed as a high-risk pregnancy with delivery where HBIG and vaccine are available

  • (c) delivered by caesarean routinely

  • (d) offered termination

Show answer

Answer: (b) — NACO.


Q27. The newborn of an HBsAg-positive mother should receive

  • (a) nothing until tested

  • (b) vaccine at 6 weeks only

  • (c) HBIG alone

  • (d) HBIG plus hepatitis B vaccine immediately after delivery

Show answer

Answer: (d) — NACO.


Q28. Under India's UIP, the hepatitis B birth dose is given

  • (a) at 6 weeks

  • (b) at 9 months

  • (c) only to high-risk babies

  • (d) as early as possible, within 24 hours

Show answer

Answer: (d) — UIP 2026.


Q29. The commonest mode of hepatitis B spread emphasised in NACO counselling is

  • (a) mosquitoes

  • (b) mother to newborn

  • (c) casual contact

  • (d) food

Show answer

Answer: (b) — NACO.


Q30. Non-immune household contacts of a patient with hepatitis A can be protected by

  • (a) HBIG

  • (b) standard immune globulin (or vaccine)

  • (c) nothing works

  • (d) acyclovir

Show answer

Answer: (b) — MSD.

Active Recall

From memory: give the genome, route and chronicity of hepatitis A to E, explain the HBV serological markers and window period, state chronicity by age and cancer risk, outline HCV genotypes and treatment, distinguish HDV coinfection from superinfection, describe HEV, and state India's HBV screening and newborn prophylaxis policy.